Menu Search
Equities

Bangkok Dusit Medical Services PCL

BDMSF:PKL

Bangkok Dusit Medical Services PCL

Actions
  • Price (USD)--
  • Today's Change--
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Bangkok Dusit Medical Services Public Company Limited is a Thailand-based company, which is engaged in providing medical services. The Company operates through two segments, which consist of hospital operations and other businesses that support hospitals, other businesses such as medical laboratories, production and distribution of pharmaceutical products, pharmacies, asset management for healthcare business, accounting services, technology and information services, training business, and insurance broker. The Company consists of over six main hospital groups: Bangkok Hospital Group, Samitivej Hospital Group, BNH Hospital, Phyathai Hospital Group, Paolo Hospital Group, and the Royal Hospital Group, with a total of approximately 47 hospitals. The Company is involved in businesses related to healthcare prevention, rehabilitation, and medical support services through its subsidiaries, such as BDMS Wellness Clinic Company Limited and BDMS Wellness Resort Company Limited.

  • Revenue in THB (TTM)106.81bn
  • Net income in THB15.61bn
  • Incorporated1969
  • Employees36.25k
  • Location
    Bangkok Dusit Medical Services PCL2 Soi Sunwichai 7New Phetchaburi Road, BangkapiHuaikhwangBangkok 10310ThailandTHA
  • Phone+66 23103000
  • Fax+66 23181546
  • Websitehttps://www.bdms.co.th/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.